Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2025-12-27 @ 9:14 PM
Study NCT ID:
NCT03937895
Status:
COMPLETED
Last Update Posted:
2022-03-29
First Post:
2019-04-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer
Sponsor:
SMT bio Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SNK-SIT-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None